LEARNING OBJECTIVES

 

At the conclusion of this activity, participants will be able to:

 

1.  Describe the various clinical phenotypes of inflammatory arthritis due to checkpoint inhibitor therapy.

2. Delineate ways in which immune checkpoint inhibitor-induced inflammatory arthritis can serve as a model of autoimmune arthritis

3.  Discuss critical practice points for ICI-arthritis management

Session date: 
10/25/2022 - 8:30am to 9:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Pankti Reid, M.D.